Abstract
INTRODUCTION
Endoscopic resection (ER) is a minimally invasive technique aimed at staging or curing dysplastic lesions and intramucosal cancers of the gastrointestinal tract. ER includes endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), their res pective application mainly depending on the size of the tumour [1] . EMR was the first endoscopic treatment proven to be as effective as gastrectomy at managing early gastric cancers, with curative rates as high as 85% [1] . However, in lesions larger than 20mm, ESD is preferred as it can achieve higher rates of enbloc resections and consequently lower recurrence rates [17] . En-bloc resections almost constitute a prerequisite for accurate histological evaluation of the resected specimen.
ER is also considered the only definitive method of excluding invasion in otherwise precancerous lesions, where time and again, endoscopic biopsies and endoluminal ultrasound have proven inadequate [2, 8, 9] . ER can change the diagnosis in up to 40% of cases, more commonly resulting in an upstaging [1012] . It provides vital information about the depth of invasion of the tumour and as the latter constitutes the strongest predictor of lymph node metastasis [13, 14] , it is used to guide subsequent management decisions, in particular the indication for surgery. When compared to surgery, ESD appears to have comparable oncologic outcomes with the advantage of shorter operation times, shorter hospital stays and lower complication rates [15] . Most evidence for the efficacy and safety of ESD comes from Eastern countries, where ESD has been shown to achieve curative resection (CR) rates as high as 97% in lesions that meet the Japanese Gastric Cancer Association (JGCA) guidelines [1618] . Despite being a technically challenging procedure and carrying a high risk of adverse events in inexperienced hands [19] , ESD is gradually gaining popularity in Western countries, partly facilitated by technological advancements [20] . However, evidence for ESD is still scarce in Western populations. One of the few studies carried out in Germany showed promising results with a high rate of enbloc resections and remarkably low recurrence rates of 1.5% [21] . In the United Kingdom, the JGCA criteria guidelines are used to select lesions amenable to ESD. However, since the outcomes of ESD are heavily dependent on the level of skills of the endoscopist, more local studies are crucial [22, 23] . The National Institute of Health and Care Excellence in the United Kingdom only take into account United Kingdom studies when formulating local clinical guidelines. No studies have considered the efficacy of gastric ESD in a United Kingdom Caucasian population up to this date.
MATERIALS AND METHODS
This retrospective study is part of our service develop ment and audit and aims to investigate the efficacy of ESD at treating early neoplastic lesions of the stomach in a Caucasian population at a tertiary referral centre in the United Kingdom and secondly, its application for staging early cancers.
Inclusion criteria: Data was obtained for a period of 2 years from May 2015 to June 2017. Only Caucasian patients with gastric cancers staged at or below T1a N0M0 on the basis of computed tomography (CT) scans (or Positron Emission TomographyComputed Tomography (PETCT) in a few cases) and Endoscopic Ultrasound (EUS) were included in this study.
Exclusion criteria: Patients with gastric cancers staged at T1bN0M0 or above were excluded from the study on the basis of CT scans (or PETCT scans in a few cases) and EUS .
Mapping oesophagogastroduodenoscopy (mapping OGD, a preESD check to evaluate if the case is suitable for ESD) was used to assess the macroscopic appearance of the lesions, the position and size, the presence of ulceration, any field changes and importantly whether the lesions were liftable. The degree of lift of each lesion was graded according to the Kato classification where Kato 1 denotes lifting without any resistance, Kato 2 lifting with some resistance and Kato 3 no lifting [24] . Endoscopic imaging enhancements used included White Light Imaging, Olympus Narrow Band Imaging (NBI) or Fuji Fluorescent Intelligent Chromoendoscopy, indigo carmine spray and acetic acid spray. Biopsies were taken prior to any intervention to assess or reassess the type of neoplasia present and the degree of differentiation. Poor differentiation and nonlifting sign (Kato 3) precluded ESD except in one patient whose comorbidities notably liver cirrhosis Child's Grade A made him unfit for surgery. Endoscopy reports, histology reports and multi disciplinary team (MDT) meeting letters were retrieved from the electronic patient record of the hospital. The information about each patient's demographic data, pre ESD endoscopic assessment, index procedure, followup endoscopy, surgery and outcome at the latest follow up were recorded. Microsoft Excel has been used to record all data and for all statistical analyses.
Olympus Double Channel DoubleHeaded Scope or Fuji Dual Channel Endoscope were used in all procedures and the procedures were jointly performed by two experienced interventional gastroenterologists. The ESD procedure was carried out in theatre (operating room) with the patient under general anaesthesia. The patient was intubated with the assistance of an anaesthetist and endoscopy performed using carbon dioxide gas only. The ESD equipment used for dissection included Olympus ITknife2 Electrosurgical Knife (KD611L), Olympus ITknife nano Electrosurgical Knife (KD-612L/U), Fujifilm Flush Knife, Fujifilm Clutch Clutter and ERBE Hybrid O Knife. A soft transparent hood (D20113404; Olympus, Tokyo, Japan) was attached to the tip of the endoscope to obtain good endoscopic views of the submucosal layer. In some cases, additional image enhancing techniques (as outlined above) had to be used. This was done through a 2channel scope equipped with multibending and water jet functions attached to the tip of the endoscope. The lesions were lifted with EMR solution and marking dots were placed using argon on the normal mucosa at approximately 5 mm from the tumour margin to provide safety margins. EMR solution (consisting of a small amount of indigo carmine and 0.1% lidocaine) was then injected into the submucosal layer and a mucosal incision made outside the marking dots. In case of poor mucosal elevation due to ulceration of the lesion or extensive fibrosis of the submucosal layer, hyaluronic acid solution was added to the injection solution to achieve better lift. After mucosal incision, dissection of the submucosal layer was performed, thus achieving en bloc resection.
Each patient was given oral Omeprazole 40 mg, twice daily for at least 3 mo (or another equivalent proton pump inhibitor) after the procedure.
The resected specimen was cut into 4mmthick slices after formalin fixation. The histological type, size, depth of invasion, horizontal and vertical margins (HM and VM respectively), and lymphovascular invasion were evaluated in each slice according to the JGCA Japanese Classification of Gastric Carcinoma criteria. To reconcile and allow for the efficacy of ESD to be more accurately investigated in Western populations, a more systematic approach to reporting histological findings such as the Vienna classification was also used [25] . The measure of efficacy in this study is CR. A resection is considered curative if it achieves clear vertical and horizontal margins and if histological evaluation of the resected specimen shows neither poor differentiation, nor lymphovascular invasion nor submucosal involvement [3] . An ESD resection is coded as nonCR if it fails to meet all aforementioned criteria and as "indefinite" if data is inadequate to confirm either CR or non-CR. All resected lesions were coded as "complete resection on endoscopy" unless otherwise specified; a resection was considered to be "complete resection on histology" if the VM and the horizontal margin (HM) were clear on histology. The position of lesion was coded as Upper stomach if it was found in the cardia or fundus, as Mid stomach if in the body and as Lower stomach if in the antrum, pylorus or incisura. The age of the patient was at the time of the index procedure.
The secondary endpoint was complete reversal of dysplasia at 12 mo endoscopic followup and/or at the latest follow-up and was investigated in the "indefinite" group and the CR group. The schedule for endoscopic surveillance for site check is 3 mo after the procedure and then 6 monthly for first year and then yearly thereafter, for 5 years. This outcome considers a patient as one entity, regardless of the number of ESD resections he/she may have had. The change in histological diagnosis pre and post ESD has also been recorded to assess the ability of ESD to influence diagnosis. The histological diagnosis is recorded as the worst histological grade reported for each lesion.
RESULTS
There were 24 patients with gastric dysplasia and/or neoplasia who were considered for endoscopic treatment using ESD. The demographic data of patients included in the study are shown in Table 1 . Out of the 24 patients identified for the study, 19 were deemed suitable for ESD after mapping OGD. ESD was attempted on a total of 25 dysplastic or neoplastic lesions, among which 21 were completed and the patients then followed up or offered further treatment based on histology of the resected specimens, and 4 aborted ( Figure 1 ). There were 5 patients who were found to be unsuitable for ESD after mapping OGD.
Pre-ESD endoscopic assessment
Most lesions were reported as Kato 1, one lesion as Kato 2 and one as Kato 2 to 3. The mean size of lesions resected was 24.7 mm (standard deviation 11.7 mm; range 1050 mm). Figure 2 shows a lesion suitable for ESD and the procedure in sequence. The main contraindicative features in lesions unsuitable for ESD were ulceration and poor differentiation. Poor lift, large size and deeper invasion constituted other contraindications (Table 2; Figure 2 ). In one patient, a severe oesophageal stricture prevented passage of the endoscope to assess the lesion. Features of the lesions deemed suitable for ESD are shown in Table 3 .
Index procedure: Gastric endoscopic submucosal dissection
Of the 21 resections completed successfully, enbloc resection was achieved in 71.4% of cases. Resection was considered complete on endoscopy in 90.5% of cases compared to only 38.1% on histology (Table 4) . 6 achieved a definite CR (5 patients), 5 were confirmed to be non-curative (4 patients) and 10 were indefinite (10 patients) (Figure 3 ). In the latter group, only 2 patients were considered potential candidates for surgery. The A-E: Macroscopic appearance of lesion with mapping OGD and thus suitable for ESD. This is an area extending from the antrum through to the pyloric ring. The ESD procedure is highlighted here; F: Macroscopic appearance of lesion with suspected sm3 or deeper on mapping OGD and thus unsuitable for ESD. This is an area extending from the cardia through to the upper body. ESD: Endoscopic submucosal dissection. LGD: Low grade dysplasia; HGD: High grade dysplasia; IMC: Intramucosal carcinoma.
rest were only offered endoscopic followup as complete resection had been achieved on endoscopy and no other poor prognostic features (e.g., poor differentiation) were present. Adjuvant chemo or radio therapy were not given as patients initially selected for this study had no evidence of lymph node involvement or distant metastases on CT and/or PETCT scans. The histological diagnoses of nonCR patients post ESD are shown in Table 5 .
Complications are classified as acute (during the procedure), early (< 48 h after the procedure) or late (> 48 h after the procedure). The most common acute complication reported was oozing small blood vessels (6) . In 4 of these cases, bleeding was mild and treated with argon, coagulation forceps or endoclips. In the other 2, the procedure had to be aborted due to profuse bleeding. Both cases were in the same patient. The patient was on anticoagulation for atrial fibrillation and had a normal INR after stopping warfarin for 5 d prior to ESD. The marked mucosal friability resulted in bleeding even on mild trauma from the water jet used during endoscopy (Figure 4) . A further 2 cases also had to be aborted, one due to the location of the lesion, which would have led to gastric outlet obstruction in due course and the other due to extensive scarring secondary to a previous ESD attempt. There was only one case of early complication involving vomiting within 24 h of the procedure. No cases of late complications were reported.
The median duration of the ESD procedures was found to be 120 min (with factors such as the size of the lesion, its location and tissue factors influencing the length of time required to complete the procedure).
Change in histological grade post endoscopic submucosal dissection
Gastric ESD changed the histological grade in 66.6% of the resected lesions (n = 21) (Figure 5 ), equally downgrading and upgrading the histological diagnoses. Most resected specimens were found to have HGD (5) and IMC (5), compared to the higher proportion of IMC prior to ESD. In addition, as shown in Figure 6 , lympho vascular invasion and invasive cancer were observed in 5 cases compared to only one case pre ESD. Of these 5 cases, 1 resection was found to be completely clear of dysplasia and a further case indefinite for any dysplasia on histology, but with clear evidence of invasion in both cases.
LGD was present in 4 cases. In all cases except one, the change in histological grade, if any, was by one stage.
Endoscopic follow-up
In the "indefinite" cohort of 10 patients, one declined further endoscopic followup and has been scheduled for a CT scan instead. In addition, 2 patients had not had any followup yet at the time of data collection. One passed away 1 mo after his last followup endoscopy (the cause of death is unrelated to his gastric diagnosis). The median followup period was 2 mo and the mean 5.1 mo for the "indefinite" cohort (Table 6 ). Complete reversal of dysplasia was observed in 10% and 50% of patients at 12mo and the latest followup respectively in the "indefinite" cohort ( Figure 7) . Recurrence was observed in 2 patients both had in fact been considered poor candidates for ESD at baseline due to multiple comorbidities. In the cohort considered to have achieved CR with ESD, 80% were found to be free of dysplasia at their latest endoscopic followup at a mean followup period of 6.8 mo (Figure 8 ). Hence, with both cohorts (CR and 'indefinite') combined, 9 of the 11 patients (81.8%) who had had at least one endoscopic followup were found to be free of dysplasia on endoscopy at their latest followup at a mean follow up period of 7.7 mo.
Surgery
Overall, 6 patients were considered for surgery after ESD. In the "indefinite" group, the 2 patients with recurrence at followup were referred for surgery but neither was sufficiently fit to proceed. ESD was atte mpted again but failed in both patients. They were thus listed for endoscopic surveillance. Metachronous or recurrent polyps were observed at the latest follow up for both patients at 11 and 19 mo respectively. In the group of 4 patients found to be nonCR, surgery was considered a treatment option in all of them but only one patient was sufficiently fit to proceed with gastrectomy. The rest of nonCR patients were offered either further ESD or endoscopic surveillance or palli ative care. Only 2 of the 5 patients considered unfit for ESD underwent surgery (Patients B and E; Table 2 ). Postop staging were pT3N3MxR1 and pT1bN1MxR0 (moderate to poor differentiation) respectively.
Survival rate
One ESD patient died 4 mo after ESD. ESD on this patient was considered curative and endoscopic fo llowup at 3 mo post ESD showed no macroscopic recurrence but biopsies could not be taken due to the patient's high INR. Cause of death is unrelated to his primary gastric diagnosis. Survival rate in ESD patients was 94.7% (18 out of 19 patients) at a mean followup period of 15 mo.
Another patient in the group found unsuitable for ESD died 5 mo after an attempted mapping OGD. The patient was suffering from a severe oesophageal stricture and was receiving parenteral nutrition. The overall survival rate in the entire cohort was thus 91.7% (22 out of 24 patients).
DISCUSSION
Despite the small sample size, the ability of ESD to achieve CR in carefully selected patients has been demonstrated. Approximately 28% of ESD resections (6) were considered curative. Moreover, 4 of the 5 CR patients were free of dysplasia at the latest followup while the fifth patient had not had any followup yet, thus corroborating previous studies that demonstrated the positive longterm outcomes in patients with a CR, as defined by the JGCA criteria.
Positive longterm outcomes were also observed in a large proportion of the "indefinite" patients, des pite the inability to confirm CR on histology. In the 2 patients who had recurrence of disease, histological evaluation of the ESD specimens had been particularly challenging due to marked inflammation in one case and very severe distortion of the tissue in the other. The specimen in fact reached the pathology laboratory outside formalin. NonCR could therefore not be con fidently excluded in these 2 patients and was in fact made more likely by a preESD diagnosis of IMC. It was clear however on endoscopic followups that these 2 patients had more advanced disease than suspected prior to ESD, as suggested by the presence of several metachronous and/or synchronous polyps. Overall, despite the inability to always confirm CR on histology, gastric ESD has proven itself highly effective at clearing neoplastic growth if complete resection can be achieved on endoscopy. It also points to the importance of MDT discussions to avoid unnecessary surgery in patients indefinite for CR or nonCR.
The main reason for uncertainty regarding the completeness of excision on histology was the poor preservation of the resected specimens. In many instances, the specimen had been pinned down too deeply into the polystyrene board thus inflicting sub stantial trauma to the tissue. Other artefacts such as diathermy changes at the periphery, excision margins not clearly defined and inflammation also hindered accurate interpretation. In one case, the lesion had to be resected piecemeal. Other reasons included missing report and lack of mention of margin clearance. Hence, it is clear that to allow for the efficacy of ESD to be more accurately investigated in the future, ways to satisfactorily preserve the resected specimen in its original state and implementing a more systematic approach to reporting histological findings are required. This study also demonstrates the importance of careful selections of patients at baseline. Out of the 5 nonCR resections, 3 already contained poor prognostic features at baseline. However, the MDT consensus was to proceed with ESD given the patients' multiple comorbidities that made them unfit for surgery. In one case, poor differentiation was seen prior to ESD while in the other two, invasive carcinoma had been identified. In the rest of non-CR cases, deeper invasion would have been left unnoticed had the lesion not been resected by ESD. ESD effectively identified lympho vascular invasion in these 2 lesions presumed to be IMC only prior to ESD. This observation lends support to the status of ESD as the only definitive tool to exclude invasion. Moreover, ESD changed the histological grade in 66.6% of resected lesions. Unlike more large scale studies however, ESD equally downgraded and upgraded histological diagnoses. In one exceptional case, the histological grade changed from IMC pre ESD to clear of any dysplasia or malignancy post ESD. Further investigations into this case revealed observer bias in the interpretation of preESD biopsy specimen at the patient's local hospital. ESD thus enabled the correct diagnosis to be made. This however points to a potential source of error in this study, i.e., bias in interpretation of histology slides.
Only one patient underwent surgery after a nonCR ESD. Interestingly, in this patient, the ESD scar was still present on endoscopic followup after the surgery. Deep biopsies taken from this site were all found to be clear of dysplasia, even at the latest endoscopy performed 30 mo post ESD. In this patient, ESD had revealed a welldifferentiated invasive adenocarcinoma without any lymphovascular invasion. This "invasion" constituted the indication for surgery even though the exact depth of invasion was not reported. Hence, it may be possible that ESD patients are being unnecessarily referred for surgery and that ESD alone could be sufficient to treat more advanced diseases with the advantage of shorter hospital stays and fewer complications.
Some of the other limitations of this study include relatively short followup periods preventing more accurate assessment of the longterm outcomes and potential bias in letters and endoscopy reports. Hence we plan to study a larger number of patients and have a longer followup period in order to reduce bias and truly assess the efficacy of ESD in our Caucasian United Kingdom population.
In conclusion, these results although modest are promising and provide early evidence in favour of the use of ESD in Caucasian populations in the United Kingdom. Despite the wealth of evidence for the efficacy of gastric ESD in Far Eastern countries, the National Institute of Health and Care Excellence (NICE) United Kingdom still views upper GI ESD as a procedure to be applied on a casebycase basis only with an MDT approach [22] , thus demonstrating the need for further, largerscale studies into this technique in the United Kingdom and other Western countries.
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Research background
Endoscopic submucosal dissection (ESD) is a minimally invasive technique used to treat early superficial lesions of the gastrointestinal tract. It is popular in Far East countries where its outstanding efficacy has been proven by multiple studies. Technological advances have recently made ESD more accessible worldwide. In the United Kingdom, this intervention is still relatively new and local evidence to support its use still scarce.
Research motivation
This study aims to evaluate the application of ESD in Caucasian patients in the United Kingdom and seeks to compensate for the lack of evidence in the literature in favour of its use in this country. Larger scale studies will be required in the future.
Research objectives
This study constitutes a step forward in providing the evidence necessary to support the application of ESD among Caucasian patients in the United Kingdom as well as to help produce standardised clinical guidelines to inform local clinical practice for this relatively new intervention.
Research methods
This retrospective study uses data obtained from the Department of Gastroenterology at Salford Royal NHS Foundation Trust in the United Kingdom, a tertiary centre for gastrointestinal interventions. Data for a period of 2 years has been analysed using Microsoft Excel.
Research results
Of the 21 lesions resected with ESD, 6 achieved curative resection (CR), 10 were "indefinite" for CR or non-CR, and 5 were considered non-CR. A favourable long-term outcome was observed in the CR and "indefinite" groups, with clearance of dysplasia observed overall in 81.8% of patients who had had at least one endoscopic follow-up. ESD also changed the histological diagnoses in 66.6% of cases. These results are promising and provide early evidence in favour of the use of ESD in the United Kingdom.
Research conclusions
ESD as applied to Caucasian patients in the United Kingdom can produce promising results as shown by this study. There have not been similar studies in the United Kingdom in the past and thus larger scale studies are required to fully evaluate the efficacy and safety profile of ESD as applied to upper gastrointestinal cancers.
Research perspectives
To better assess the effectiveness of ESD at clearing early neoplastic lesions of the stomach and other upper gastrointestinal cancers among Caucasian patients in the United Kingdom, a prospective study involving a larger sample of such patients is required.
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